Fennec Pharmaceuticals (FENC)

• Market cap: $222M
• 1 day: -0.25%
• 5 days: -3.16%
• 1 month: -15.82%
• 3 months: -1.12%
• 6 months: 30.61%
• Year to date: 26.87%
• 1 year: 83.03%
• 5 years: -0.87%
• 10 years: -33.5%
• Sector: Healthcare
• Industry: Biotechnology

About: Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Employees: 32